Home Cart 0 Sign in  
X

[ CAS No. 151049-87-5 ] {[proInfo.proName]}

,{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]}
3d Animation Molecule Structure of 151049-87-5
Chemical Structure| 151049-87-5
Chemical Structure| 151049-87-5
Structure of 151049-87-5 * Storage: {[proInfo.prStorage]}
Cart0 Add to My Favorites Add to My Favorites Bulk Inquiry Inquiry Add To Cart

Quality Control of [ 151049-87-5 ]

Related Doc. of [ 151049-87-5 ]

Alternatived Products of [ 151049-87-5 ]

Product Details of [ 151049-87-5 ]

CAS No. :151049-87-5 MDL No. :MFCD11110668
Formula : C4H5BrN2 Boiling Point : -
Linear Structure Formula :- InChI Key :ZGEVJEQMVRIEPX-UHFFFAOYSA-N
M.W : 161.00 Pubchem ID :14948637
Synonyms :

Calculated chemistry of [ 151049-87-5 ]

Physicochemical Properties

Num. heavy atoms : 7
Num. arom. heavy atoms : 5
Fraction Csp3 : 0.25
Num. rotatable bonds : 0
Num. H-bond acceptors : 1.0
Num. H-bond donors : 0.0
Molar Refractivity : 31.19
TPSA : 17.82 Ų

Pharmacokinetics

GI absorption : High
BBB permeant : Yes
P-gp substrate : No
CYP1A2 inhibitor : No
CYP2C19 inhibitor : No
CYP2C9 inhibitor : No
CYP2D6 inhibitor : No
CYP3A4 inhibitor : No
Log Kp (skin permeation) : -6.39 cm/s

Lipophilicity

Log Po/w (iLOGP) : 1.68
Log Po/w (XLOGP3) : 1.26
Log Po/w (WLOGP) : 1.18
Log Po/w (MLOGP) : 0.81
Log Po/w (SILICOS-IT) : 1.14
Consensus Log Po/w : 1.21

Druglikeness

Lipinski : 0.0
Ghose : None
Veber : 0.0
Egan : 0.0
Muegge : 2.0
Bioavailability Score : 0.55

Water Solubility

Log S (ESOL) : -2.16
Solubility : 1.11 mg/ml ; 0.00691 mol/l
Class : Soluble
Log S (Ali) : -1.23
Solubility : 9.42 mg/ml ; 0.0585 mol/l
Class : Very soluble
Log S (SILICOS-IT) : -1.64
Solubility : 3.71 mg/ml ; 0.023 mol/l
Class : Soluble

Medicinal Chemistry

PAINS : 0.0 alert
Brenk : 0.0 alert
Leadlikeness : 1.0
Synthetic accessibility : 1.54

Safety of [ 151049-87-5 ]

Signal Word:Warning Class:N/A
Precautionary Statements:P261-P305+P351+P338 UN#:N/A
Hazard Statements:H302-H315-H319-H335 Packing Group:N/A
GHS Pictogram:

Application In Synthesis of [ 151049-87-5 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Upstream synthesis route of [ 151049-87-5 ]
  • Downstream synthetic route of [ 151049-87-5 ]

[ 151049-87-5 ] Synthesis Path-Upstream   1~3

  • 1
  • [ 124-38-9 ]
  • [ 151049-87-5 ]
  • [ 25016-20-0 ]
Reference: [1] Journal of Heterocyclic Chemistry, 1992, vol. 29, # 5, p. 1357 - 1359
  • 2
  • [ 1904-31-0 ]
  • [ 151049-87-5 ]
YieldReaction ConditionsOperation in experiment
818 mg
Stage #1: With hydrogen bromide; sodium nitrite In water for 0.5 h; Cooling with ice
Stage #2: for 30 h; Cooling with ice
A)
3-bromo-1-methyl-1H-pyrazole
To a solution of 1-methyl-1H-pyrazol-3-amine (2.00 g) in hydrobromic acid (14.0 mL) was slowly added an aqueous solution (2.06 mL) of sodium nitrite (1.56 g) under ice-cooling.
The reaction mixture was stirred under ice-cooling for 30 min, and a solution of copper(I) bromide (7.39 g) in hydrobromic acid (14.0 mL) was slowly added thereto.
The reaction mixture was stirred under ice-cooling for 30 hr, neutralized with saturated aqueous sodium hydrogen carbonate solution, and diluted with dichloromethane.
The insoluble substance was removed by filtration, the filtrate was washed with water and saturated brine, and dried over anhydrous magnesium sulfate, and the solvent was evaporated under reduced pressure.
The residue was purified by silica gel column chromatography (ethyl acetate/hexane) to give the title compound (818 mg).
1H NMR (400 MHz, CDCl3) δ 3.88 (3H, s), 6.25 (1H, d, J = 2.4 Hz), 7.25 (1H, d, J = 2.0 Hz).
Reference: [1] Journal of Organic Chemistry, 1991, vol. 56, # 22, p. 6313 - 6320
[2] Patent: EP2818473, 2014, A1, . Location in patent: Paragraph 0577
[3] Synthesis (Germany), 2015, vol. 47, # 5, p. 679 - 691
  • 3
  • [ 151049-87-5 ]
  • [ 73183-34-3 ]
  • [ 1020174-04-2 ]
YieldReaction ConditionsOperation in experiment
44.19% With dichloro(1,1'-bis(diphenylphosphanyl)ferrocene)palladium(II)*CH2Cl2; potassium acetate In 1,4-dioxane at 95℃; for 5 h; Inert atmosphere Intermediate 702: 1-methyl-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazole
Compound 701 (0.2 g, 1.24 mmol) was dissolved in 5 ml of 1,4-dioxane, added with 0.378 g (1.49 mmol) of bis(pinacolato)diboron, 0.365 g (3.72 mmol) of potassium acetate, and 0.11 g (0.124 mmol) of [1,1-bis(di-phenylphosphino)ferrocene]palladium chloride dichloromethane complex under the protection of nitrogen, heated to 95 °C and reacted for 5 h, and then cooled to room temperature. 15 mL of water was added, stirred for 1 h, and filtered to afford 0.114 g of solid. Yield: 44.19percent.
Reference: [1] Patent: EP3072893, 2016, A1, . Location in patent: Paragraph 0394; 0395
[2] Patent: EP2818473, 2014, A1, . Location in patent: Paragraph 0578
Same Skeleton Products
Historical Records

Related Functional Groups of
[ 151049-87-5 ]

Bromides

Chemical Structure| 14521-80-3

[ 14521-80-3 ]

3-Bromo-1H-pyrazole

Similarity: 0.86

Chemical Structure| 5744-80-9

[ 5744-80-9 ]

3-Bromo-1,5-dimethyl-1H-pyrazole

Similarity: 0.77

Chemical Structure| 1203705-55-8

[ 1203705-55-8 ]

3-Bromo-1H-pyrazol-5-amine

Similarity: 0.74

Chemical Structure| 57097-81-1

[ 57097-81-1 ]

3-Bromo-5-methyl-1H-pyrazole

Similarity: 0.73

Chemical Structure| 528878-44-6

[ 528878-44-6 ]

4-(Bromomethyl)-1-methyl-1H-pyrazole hydrobromide

Similarity: 0.73

Related Parent Nucleus of
[ 151049-87-5 ]

Pyrazoles

Chemical Structure| 14521-80-3

[ 14521-80-3 ]

3-Bromo-1H-pyrazole

Similarity: 0.86

Chemical Structure| 930-36-9

[ 930-36-9 ]

1-Methylpyrazole

Similarity: 0.78

Chemical Structure| 5744-80-9

[ 5744-80-9 ]

3-Bromo-1,5-dimethyl-1H-pyrazole

Similarity: 0.77

Chemical Structure| 1203705-55-8

[ 1203705-55-8 ]

3-Bromo-1H-pyrazol-5-amine

Similarity: 0.74

Chemical Structure| 528878-44-6

[ 528878-44-6 ]

4-(Bromomethyl)-1-methyl-1H-pyrazole hydrobromide

Similarity: 0.73